Administration‐Time‐Dependent Effects of Olmesartan on the Ambulatory Blood Pressure of Essential Hypertension Patients
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Previous studies established that a single daily dose of olmesartan remains effective for the entire 24 h without alteration of the day-night blood pressure (BP) pattern. On the other hand, the administration of valsartan or telmisartan at bedtime, as opposed to upon wakening, improves the sleep-time relative BP decline toward a greater dipper pattern without loss of 24 h efficacy. Yet to be determined is whether this administration-time-dependent efficacy is a class-related feature, characteristic of all angiotensin-receptor-blocker (ARB) medications. We studied 123 grade 1 and 2 hypertensive patients, 46.6+/-12.3 yrs of age, randomly assigned to receive olmesartan (20 mg/day) as a monotherapy either upon awakening or at bedtime for three months. BP was measured by ambulatory monitoring for 48 consecutive hours before and after treatment. The 24 h BP reduction was similar for both treatment times. Administration of olmesartan at bedtime, however, was significantly more efficient than morning administration in reducing the nocturnal BP mean. The sleep-time relative BP decline was slightly reduced with olmesartan ingestion upon awakening but significantly increased with ingestion at bedtime, thus reducing the prevalence of non-dipping from baseline by 48%. Olmesartan administration at bedtime, as opposed to in the morning, improved the awake/asleep BP ratio toward a greater dipper pattern without loss of 24 h efficacy. Nocturnal BP regulation was significantly better achieved with bedtime as compared to morning dosing of olmesartan. These effects are comparable to those previously reported for valsartan and telmisartan, thus suggesting that they may be class-related features of ARB medications in spite of differences in their half-life kinetics. These administration-time-dependent effects should be taken into account when prescribing ARB medications for treatment of essential hypertension.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pickering, T. G., Hall, J. E., Appel, L. J., Falkner, B. E., Graves, J., Hill, M. N., Jones, D. W., Kurtz, T., Sheps, S. G., & Roccella, E. J. (2005) · Circulation · doi:10.1161/01.cir.0000154900.76284.f6 · Cited by 3,985 · cited 2×
“With morning treatment, 74% of the subjects in this group showed controlled values of ABPM (i.e., values below the diagnostic thresholds mentioned above; see Mancia et al., 2007; Pickering et al., 2005).”
BackgroundMethodPickering, T. G., Hall, J. E., Appel, L. J., Falkner, B. E., Graves, J., Hill, M. N., Jones, D. W., Kurtz, T., Sheps, S. G., & Roccella, E. J. (2005) · Hypertension · doi:10.1161/01.hyp.0000150859.47929.8e · Cited by 2,051
Staessen, J. A. (1999) · JAMA · doi:10.1001/jama.282.6.539 · Cited by 1,592
Circadian variation of blood-pressure
Millar-Craig, M., Bishop, C., & Raftery, E. B. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92998-7 · Cited by 1,293
Kario, K., Pickering, T. G., Umeda, Y., Hoshide, S., Hoshide, Y., Morinari, M., Murata, M., Kuroda, T., Schwartz, J. E., & Shimada, K. (2003) · Circulation · doi:10.1161/01.cir.0000056521.67546.aa · Cited by 1,250 · cited 6×
“to be an independent predictor of stroke risk (Kario et al., 2003).”
BackgroundInfluentialDolan, E., Stanton, A., Thijs, L., Hinedi, K., Atkins, N., McClory, S., Hond, E. D., McCormack, P., Staessen, J. A., & O’Brien, E. (2005) · Hypertension · doi:10.1161/01.hyp.0000170138.56903.7a · Cited by 1,227 · cited 2×
“Independent prospective studies have also concluded that the sleeptime BP mean is a better predictor of cardiovascular mortality than the awake or the 24 h BP means (Dolan et al., 2005; Kikuya et al., 2005; Staessen et al., 1999).”
BackgroundKikuya, M., Ohkubo, T., Asayama, K., Metoki, H., Obara, T., Saito, S., Hashimoto, J., Totsune, K., Hoshi, H., Satoh, H., et al. (2005) · Hypertension · doi:10.1161/01.hyp.0000152079.04553.2c · Cited by 417
Cited by
Hermida, R. C., Ayala, D. E., Mojón, A., & Fernández, J. R. (2010) · Chronobiology International · doi:10.3109/07420528.2010.510230 · Cited by 608
“…to morning-dosing schedule of most BP-lowering medications (Hermida & Bedtime Chronotherapy for Cardiovascular Risk Reduction 1645 Ayala, 2009; Hermida et al., 2003, 2007b, 2007c, 2008c, 2009; Lemmer, 2000; Smolensky et al., 2010; Tofé & García, 2009); this treatment schedule best reduces…”
BackgroundInfluentialSelf-citationMedicine in the Fourth Dimension
Cederroth, C. R., Albrecht, U., Bass, J., Brown, S. A., Dyhrfjeld-Johnsen, J., Gachon, F., Green, C. B., Hastings, M. H., Helfrich-Förster, C., Hogenesch, J. B., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.06.019 · Cited by 359
Hermida, R. C., Ayala, D. E., Mojón, A., & Fernández, J. R. (2013) · Chronobiology International · doi:10.3109/07420528.2012.701127 · Cited by 203
Self-citationChronotherapy With Low-Dose Aspirin for Prevention of Complications in Pregnancy
Ayala, D. E., Ucieda, R., & Hermida, R. C. (2013) · Chronobiology International · doi:10.3109/07420528.2012.717455 · Cited by 203
“…ASA (100 mg/d) on ambulatory BP was demonstrated in randomized prospective trials on normotensive subjects (Hermida et al., 1997b), individuals with prehypertension (Hermida et al., 2009b), and patients with untreated mild hypertension (Ayala & Hermida, 2010; Hermida et al., 2003a, 2005a, 2005b).”
BackgroundResultSelf-citationHermida, R. C., Ayala, D. E., Fernandez, J. R., Portaluppi, F., Fabbian, F., & Smolensky, M. H. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2010.217 · Cited by 159
Self-citation
Metadata
- Authors
- Hermida, R. C., Ayala, D. E., Chayán, L., Mojón, A., & Fernández, J. R.
- Venue
- Chronobiology International
- Publisher
- Informa UK Limited
- Published
- 2009-01
- Volume
- 26
- Issue
- 1
- Pages
- 61-79
- ISSN
- 0742-0528 (ISSN-L)
- 1525-6073
- OpenAlex
- W1974849071
- Cited by
- 97
- References
- 7
- FWCI
- 7.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Administration‐Time‐Dependent Effects of Olmesartan on the Ambulatory Blood Pressure of Essential Hypertension Patients. https://app.cochat.ai/papers/10.1080/07420520802548135
- The paper
- Hermida, R. C., Ayala, D. E., Chayán, L., Mojón, A., & Fernández, J. R. (2009). Administration‐Time‐Dependent Effects of Olmesartan on the Ambulatory Blood Pressure of Essential Hypertension Patients. Chronobiology International. https://doi.org/10.1080/07420520802548135
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.